FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/10/037519 [Registered on: 25/10/2021] Trial Registered Prospectively
Last Modified On: 19/09/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   EFFECT OF ARAGVADHADYAM TAILAM AND DHATRI KHADIR KWATH ON VITILIGO 
Scientific Title of Study   A PHARMACEUTICO-CLINICAL STUDY OF ARAGVADHADYAM TAILAM AND DHATRI KHADIR KWATH ON SHVITRA WITH SPECIAL REFRENCE TO VITILIGO 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR MUKESH KUMAR 
Designation  MD(AY) SCHOLAR 
Affiliation  goverment ayurvedic college,patna 
Address  GOVERMENT AYURVEDIC COLLEGE AND HOSPITAL ,WEST LOHANIPUR,BUDHHA MURTI, PATNA

Patna
BIHAR
800003
India 
Phone  9835839715  
Fax    
Email  mukeshkr8088@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR NEETU SINGH 
Designation  ASST.PROFFESOR 
Affiliation  goverment ayurvedic college,patna 
Address  GOVERMENT AYURVEDIC COLLEGE AND HOSPITAL ,WEST LOHANIPUR,BUDHHA MURTI, PATNA

Patna
BIHAR
800003
India 
Phone  7091141115  
Fax    
Email  singhneetu17@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR NEETU SINGH 
Designation  ASST.PROFFESOR 
Affiliation  goverment ayurvedic college,patna 
Address  GOVERMENT AYURVEDIC COLLEGE AND HOSPITAL ,WEST LOHANIPUR,BUDHHA MURTI, PATNA

Patna
BIHAR
800003
India 
Phone  7091141115  
Fax    
Email  singhneetu17@gmail.com  
 
Source of Monetary or Material Support  
Government Ayurvedic College Patna 
 
Primary Sponsor  
Name  GOVERMENT AYURVEDA COLLEGE AND HOSPITAL PATNA 
Address  GOVERMENT AYURVEDA COLLEGE AND HOSPITAL,WEST LOHANIPUR,BUDHHA MURTI,KADAMKUAN,PATNA 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
nil  nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR MUKESH KUMAR  Government Ayurvedic College Hospital Patna  Department of Research (Rasa Sashtra and Bhaishajya Kalpana), OPD Room No: 10, Government Ayurvedic College and Hospital Patna, Kadamkuan, Near Buddh Murthi, Bihar 800003
Patna
BIHAR 
9835839715

mukeshkr8088@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:L00-L99||Diseases of the skin and subcutaneous tissue. Ayurveda Condition: SVITRAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Dhatri khadir kwath, Reference: chakradutta, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: Bakuchi churna taken with Dhatri khadir kwath
(2) Medicine Name: Aragvadhadyam tailam, Reference: Chakradutta, Route: Topical, Dosage Form: Taila, Dose: 2.5(ml), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: for external application as per requirement
(3) Medicine Name: Dhatri khadir kwath and Aragvadhadyam tailam, Reference: Chakradutta, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 50(ml), Frequency: bd, Bhaishajya Kal: Antarabhakta, Duration: 90 Days, anupAna/sahapAna: No, Additional Information: Dhatri khadir Kwath should be taken with Bakuchi churna and Aragvadhadyam tailam should be used topical
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patient willing for trial, having signs and symptoms (classical along with some modern parameters). 
 
ExclusionCriteria 
Details  Patients suffering from AIDS, Cancer, TB, Cardiac complications, patients of Sprue disease, Malabsorption, HB% below 7gm/dl, pregnant women. Vitiligo patches that rapidly spread and become associated with redness, blister formation, itching during therapy or as such. 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
Improvement in signs and symptoms of Shvitra.  90 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in signs and symptoms of Shvitra.  Evaluation will be done after 90 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "58"
Final Enrollment numbers achieved (India)="58" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   25/10/2021 
Date of Study Completion (India) 02/06/2022 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Shvitra is considered as one of the varieties of Kushtha, that can be correlated with Vitiligo based on the similarities of signs and symptoms. It is caused due to the vitiation of tridosha and dhathus like rasa, rakta, mamsa and meda. Dhatri khadir kwath and Aragvadhadyam tailam yoga are formulations described in chapter Kushtha Chikitsa of Chakradutta for Shvitra, are selected for the present study. 
Close